market access
Nice extends price-negotiation talks for PTC’ muscle wasting drug
May 4, 2016Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, NICE, PTC Therapeutics, Translarna, market access, regulation
UK regulators have extended the cost negotiation talks with PTC Therapeutics (Nasdaq: PTCT) by a week for the drug to …
Two billion people still lack medicines access. Is the industry doing enough?
December 22, 2015Manufacturing and Production Access to Medicine Foundation, Access to Medicine Index, affordability, market access, medicines access, pricing
“We have a mission to encourage the pharmaceutical industry in improving access to medicine for the two billion people who …
Obama government launches drug price crackdown
November 4, 2015Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, President Obama, US, affordability, market access
President Obama has launched an ‘Affordable Drug Pricing Task Force’, aimed at tackling the spiralling cost of certain prescription medications …
NICE launches new service to speed NHS adoption of health technologies
October 13, 2015Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, OMA, market access, office for market access
NICE is introducing a new service, the Office for Market Access (OMA), to work with industry to speed up NHS …
Pharma ‘is getting better at drug R&D’
September 23, 2015Research and Development R&D, drug development, market access, productivity
An investigation into pharma R&D data shows that drugmakers are becoming more successful at identifying the right candidates for drug …
EMA launches project to boost early patient access to drugs
September 8, 2015Research and Development EMA, European Medicines Agency, MAPPs, adaptive pathways, drug development, market access
The EMA is launching an adaptive pathway project to bring new medicinal products to market in Europe. The ADAPT SMART …
ABPI ‘deeply concerned’ by slow UK drugs uptake
September 7, 2015Sales and Marketing ABPI, PPRS, Pharmaceutical Price Regulation Scheme, drugs bill, market access, medicines bill
The UK pharma industry paid £209 million to underwrite the UK medicines bill in second quarter of 2015, according to …
Novo Nordisk pulls Tresiba in Germany after pricing row
July 6, 2015Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access
Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …
NICE sets out office for market access plans
May 28, 2015Sales and Marketing ABPI, EMA, NHS, NICE, eams, market access
The UK healthcare watchdog NICE is to set up a new office for market access to advise pharma companies on …
Refining UK market access
April 7, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, UK, health, market access
“Some people have said NICE needs to change, it needs to create a new vision, but we say we need …
Celgene UK: market access is a complex business
December 15, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abraxane, CDF, Cancer, Celgene, PPRS, Revlimid, market access, sam pierce
Being a firm that specialises in cancer drugs, Celgene UK is no stranger to England’s notoriously rigorous approach to expensive …
NICE reform put on hold – for now
September 17, 2014Sales and Marketing Dillon, NHS, NHS England, NICE, market access, vba
The reforming of NICE has been put on hold as the watchdog believes more changes must be wrought to deal …
China: a dangerous game that pharma must play
September 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, chinese, emerging, market access, pharma, susie lunt
Set to be the biggest country for pharma growth in the 21st century, with rising levels of chronic disease, an …
Brazil focus: not just another BRIC in the wall
April 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BRIC, Brazil, emerging markets, market access, rio
Population: 198.7 million (2012) Government: Federal presidential republic Leader: President Dilma Rousseff of the centre-left Workers’ Party Gross Domestic Product: …
The new NHS: a marriage of inconvenience?
August 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, NHS England, andy lee, market access, quarry house
As NHS England tries to squeeze more money out of the healthcare budget to pay for specialist commissioning, Andy Lee …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
